TipRanks
Decoy Therapeutics (DE:FP11)
FRANKFURT:FP11
Germany Market
FP11
Decoy Therapeutics
RESEARCH TOOLSreports

Decoy Therapeutics (FP11) Income Statement

0 Followers

Decoy Therapeutics Income Statement

Last quarter (Q2 2026), Decoy Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Decoy Therapeutics's net income was $-2.37M. See Decoy Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -8.52M$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 4.10M$ 5.73M$ 12.89M$ 31.84M$ 12.81M
Depreciation and Amortization
$ 7.15K$ 4.42K$ 10.05K$ 6.68K$ 19.18K
EBITDA
$ -12.51M$ -5.57M$ -12.53M$ -22.97M$ -12.75M
Operating Income
$ -12.61M$ -5.73M$ -12.89M$ -31.84M$ -12.81M
Other Income/Expenses
$ 95.47K$ 158.54K$ 352.25K$ 233.18K$ 44.69K
Pretax Income
$ -12.52M$ -5.58M$ -12.54M$ -31.61M$ -12.77M
Net Income
$ -12.52M$ -5.58M$ -12.54M$ -31.61M$ -12.77M
Per Share Metrics
Basic EPS
$ -25.99$ -86.92$ -461.04$ -1.79K$ -926.01
Diluted EPS
$ -25.99$ -86.92$ -461.04$ -1.79K$ -926.01
Weighted Average Shares Outstanding
 481.59K 64.15K 27.20K 17.70K 13.79K
Weighted Average Shares Outstanding (Diluted)
 481.59K 64.15K 27.20K 17.70K 13.79K
Currency in USD

Decoy Therapeutics Earnings and Revenue History